Publications by authors named "Evelyn Guedri"

Background: There is a need for a simple and efficacious treatment for cutaneous leishmaniasis with an acceptable side-effect profile.

Methods: We conducted a randomized, vehicle-controlled phase 3 trial of topical treatments containing 15% paromomycin, with and without 0.5% gentamicin, for cutaneous leishmaniasis caused by Leishmania major in Tunisia.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Evelyn Guedri"

  • - Evelyn Guedri's research primarily focuses on exploring effective treatments for cutaneous leishmaniasis, aiming to improve patient outcomes with minimal side effects.
  • - In her notable 2013 study, she conducted a randomized, vehicle-controlled phase 3 trial comparing the efficacy of topical paromomycin alone versus in combination with gentamicin for treating leishmaniasis caused by Leishmania major.
  • - The findings indicated that the topical treatment options presented a promising approach to treating cutaneous leishmaniasis, thereby addressing a significant public health need in affected regions like Tunisia.

A PHP Error was encountered

Severity: Notice

Message: fwrite(): Write of 34 bytes failed with errno=28 No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 272

Backtrace:

A PHP Error was encountered

Severity: Warning

Message: session_write_close(): Failed to write session data using user defined save handler. (session.save_path: /var/lib/php/sessions)

Filename: Unknown

Line Number: 0

Backtrace: